Rockwell expands distribution in Dominican Republic, Bermuda

WIXOM–Rockwell Medical Inc., developers of hemodialysis products, announced that it entered into a new and expanded distribution agreement with BioNuclear and Atlantic Medical International, respectively. In the aggregate, these agreements are expected to generate approximately $1 million in annual revenues for the Company.

BioNuclear specializes in the marketing of reagents, equipment and furniture for clinical laboratories, medical equipment and devices, vaccines for human consumption and supplies for hemodialysis and peritoneal dialysis. Rockwell Medical signed a five-year distributor agreement with BioNuclear through which BioNuclear may import, sell, promote and distribute Rockwell Medical’s hemodialysis concentrates products within the Dominican Republic. The agreement will remain in effect for five years and BioNuclear has the option to extend the agreement for an additional five years beyond the original term.

AMI is Bermuda’s leading supplier of medical products and equipment for the acute and continuing care markets. AMI has been a distributor of Rockwell Medical products since 2022 at which time the Company signed a five-year distribution agreement with AMI with the option to extend the agreement. The amended distribution agreement between Rockwell Medical and AMI expands the list of hemodialysis products that AMI is purchasing from the Company, includes purchasing commitments, and generates a profit margin consistent with Rockwell Medical’s gross margin guidance for 2024.

“The global reach of our hemodialysis concentrates products continues to grow,” said Tim Chole, senior vice president of sales and marketing at Rockwell Medical. “Through distribution arrangements such as these with BioNuclear and AMI, we continue to execute against our strategy and vision to become the leading supplier of hemodialysis concentrates worldwide.”

More at www.RockwellMed.com.

 

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.